Skip to main content
OpenTrials
Completed

NCT Number: NCT01859156

End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning

The purpose of this study is to determine whether a relationship exists between EtCO2 and carboxyhemoglobin levels in carbon monoxide exposure. Our hypothesis is that a liner relationship exists between EtCO2 and carboxyhemoglobin in carbon monoxide poisoning.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hennepin County Medical Center

Minneapolis, Minnesota, 55415, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Carbon monoxide exposure

Exclusion criteria

  • Less than 18 years old
  • Suicide attempt
  • Unable to provide informed consent
  • Pregnant

Treatment and study plan

Primary outcomes

  1. EtCO2

    Time frame: Immediately upon study enrollment, an average time of 30 minutes post arrival to the hospital.

    The EtCO2 level is measured by capnography and compared to the carboxyhemoglobin level.

Sponsors and collaborators

Lead sponsor

Hennepin Healthcare Research Institute

Other

Registry information

Official study title

End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide

Important dates

Study start
2006
Primary completion
2014
Study completion
2014
First posted
May 21, 2013
Registry last updated
Oct 29, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.